2021
Mental health interventions following COVID-19 and other coronavirus infections: a systematic review of current recommendations and meta-analysis of randomized controlled trials
Damiano R, Di Santi T, Beach S, Pan P, Lucchetti A, Smith F, Forlenza O, Fricchione G, Miguel E, Lucchetti G. Mental health interventions following COVID-19 and other coronavirus infections: a systematic review of current recommendations and meta-analysis of randomized controlled trials. Brazilian Journal Of Psychiatry 2021, 43: 665-678. PMID: 33852690, PMCID: PMC8639008, DOI: 10.1590/1516-4446-2020-1582.Peer-Reviewed Original ResearchConceptsMental health interventionsSystematic reviewHealth interventionsCoronavirus disease 2019Non-RCT studiesCOVID-19Mental health strategiesMental health problemsMental health outcomesMental health issuesDisease 2019Psychiatric interventionCurrent recommendationsGeneral populationHealth strategiesHealth outcomesHealth problemsCoronavirus infectionHealth practitionersHealth issuesExpert recommendationsMore studiesInterventionTrialsReview
2018
Adaptive treatment strategies for children and adolescents with Obsessive-Compulsive Disorder: A sequential multiple assignment randomized trial
Fatori D, de Bragança Pereira CA, Asbahr FR, Requena G, Alvarenga PG, de Mathis MA, Rohde LA, Leckman JF, March JS, Polanczyk GV, Miguel EC, Shavitt RG. Adaptive treatment strategies for children and adolescents with Obsessive-Compulsive Disorder: A sequential multiple assignment randomized trial. Journal Of Anxiety Disorders 2018, 58: 42-50. PMID: 30025255, DOI: 10.1016/j.janxdis.2018.07.002.Peer-Reviewed Original ResearchConceptsGroup cognitive behavioral therapySequential multiple assignmentTreatment failureInitial treatmentBaseline Yale-Brown ObsessiveChildhood OCDEffective initial treatmentProvision of treatmentCompulsive Scale scoresCognitive behavioral therapyAdaptive treatment strategiesYale-Brown ObsessiveSame regimenObsessive-compulsive disorderTreatment strategiesSymptom reductionPrimary analysisScale scoreFluoxetineTime pointsWeeksTreatmentChildrenEffect sizeTrials
2015
P.4.d.006 Serotonin reuptake inhibitor augmentation with n-acetylcysteine in treatment resistant ocd: a double-blind randomized controlled trial
Costa D, Diniz J, Joaquim M, Acciarito A, Rodrigues B, Oda E, Requena G, Miguel E, Shavitt R. P.4.d.006 Serotonin reuptake inhibitor augmentation with n-acetylcysteine in treatment resistant ocd: a double-blind randomized controlled trial. European Neuropsychopharmacology 2015, 25: s570. DOI: 10.1016/s0924-977x(15)30798-7.Peer-Reviewed Original ResearchN-acetylcysteineTrialsTranscranial direct current stimulation in obsessive–compulsive disorder: emerging clinical evidence and considerations for optimal montage of electrodes
Senço N, Huang Y, D’Urso G, Parra L, Bikson M, Mantovani A, Shavitt R, Hoexter M, Miguel E, Brunoni A. Transcranial direct current stimulation in obsessive–compulsive disorder: emerging clinical evidence and considerations for optimal montage of electrodes. Expert Review Of Medical Devices 2015, 12: 381-391. PMID: 25982412, PMCID: PMC5777161, DOI: 10.1586/17434440.2015.1037832.Peer-Reviewed Original ResearchConceptsTranscranial direct current stimulationDirect current stimulationSystematic reviewCurrent stimulationPotential new treatmentPre-supplementary motor areaPubMed/MEDLINEObsessive-compulsive disorder (OCD) treatmentDeep brain stimulation trialsClinical evidenceObsessive-compulsive disorderStimulation trialsDBS trialsMotor areaRTMS targetsMagnetic stimulationEligibility criteriaNeuromodulation techniquesStimulation targetsDisorder treatmentNew treatmentsBrain circuitsDifferent electrode montagesTDCS montageTrials
2014
A randomised controlled trial of a web-based educational program in child mental health for schoolteachers
Pereira C, Wen C, Miguel E, Polanczyk G. A randomised controlled trial of a web-based educational program in child mental health for schoolteachers. European Child & Adolescent Psychiatry 2014, 24: 931-940. PMID: 25395381, DOI: 10.1007/s00787-014-0642-8.Peer-Reviewed Original ResearchConceptsWaiting-list control groupMental disordersChild mental healthControl groupWeb-based programMental healthChild mental disordersWaiting list groupProgram interventionsWeb-based educational programMiddle-income countriesTreat approachIntervention groupDisordersEducational programsInterventionVideo groupTrialsCommunity resourcesFuture studiesGroupComplete casesHealthWeeks
2013
The impact of comorbid body dysmorphic disorder on the response to sequential pharmacological trials for obsessive-compulsive disorder
Diniz J, Costa D, Cassab R, Pereira C, Miguel E, Shavitt R. The impact of comorbid body dysmorphic disorder on the response to sequential pharmacological trials for obsessive-compulsive disorder. Journal Of Psychopharmacology 2013, 28: 603-611. PMID: 24288238, DOI: 10.1177/0269881113512042.Peer-Reviewed Original ResearchMeSH KeywordsAdultAntidepressive Agents, Second-GenerationAntidepressive Agents, TricyclicAntipsychotic AgentsBody Dysmorphic DisordersBrazilClomipramineComorbidityDrug Therapy, CombinationFemaleFluoxetineHumansMaleObsessive-Compulsive DisorderProspective StudiesQuetiapine FumarateRisk FactorsTreatment OutcomeConceptsBody dysmorphic disorderComorbid body dysmorphic disorderPharmacological trialsDysmorphic disorderAdult obsessive-compulsive disorder (OCD) patientsSequential treatment strategyObsessive-compulsive disorder patientsSequential treatmentFluoxetine monotherapyClinical characteristicsObsessive-compulsive disorderInitial severityTreatment strategiesDisorder patientsTreatment groupsPatientsWorse responseBDD patientsEffects of sexGEE modelTrialsDisordersSequential trialsWeeksType of augmentation
2009
Sequential Allocation to Balance Prognostic Factors in a Psychiatric Clinical Trial
Fossaluza V, Diniz J, de Bragança Pereira B, Miguel E, de Bragança Pereira C. Sequential Allocation to Balance Prognostic Factors in a Psychiatric Clinical Trial. Clinics 2009, 64: 511-518. PMID: 19578654, PMCID: PMC2705482, DOI: 10.1590/s1807-59322009000600005.Peer-Reviewed Original Research
2005
Citalopram plus reboxetine in treatment-resistant obsessive-compulsive disorder
Fontenelle L, Mendlowicz M, Miguel E, Versiani M. Citalopram plus reboxetine in treatment-resistant obsessive-compulsive disorder. The World Journal Of Biological Psychiatry 2005, 6: 57-59. PMID: 16097406, DOI: 10.1080/15622970510029740.Peer-Reviewed Original ResearchConceptsTreatment-resistant obsessive-compulsive disorderObsessive-compulsive disorderSRI-resistant obsessive compulsive disorderResistant obsessive-compulsive disorderCombination of citalopramFirst-line treatmentAdequate trialReuptake inhibitorsCompulsive disorderPatientsCitalopramDisordersFuture studiesTrials
2001
Transtorno obsessivo-compulsivo resistente: conceito e estratégias de tratamento
Shavitt R, Ferrão Y, Bravo M, Belotto C, Lopes A, Miguel E. Transtorno obsessivo-compulsivo resistente: conceito e estratégias de tratamento. Brazilian Journal Of Psychiatry 2001, 23: 52-57. DOI: 10.1590/s1516-44462001000600016.Peer-Reviewed Original ResearchSerotonin uptake inhibitorPredictive response factorsNon-pharmacological approachesTranscranial magnetic stimulationResistant casesAppropriate trialsPharmacological trialsMagnetic stimulationUptake inhibitorConventional treatmentBehavioral therapyPatientsOCD patientsBehavior therapyTherapyTrialsTreatmentAugmentation strategiesFurther researchMedicationsPathophysiologyPharmacogenetics